昭衍新药(603127.SH)发2023年业绩，净利润3.97亿元，同比下降63.04%

智通财经03-28

智通财经APP讯，昭衍新药(603127.SH)发布2023年年度报告，实现营业收入23.76亿元，同比增长4.78%。实现归属于上市公司股东的净利润3.97亿元，同比下降63.04%。实现归属于上市公司股东的扣除非经常性损益的净利润3.38亿元，同比下降66.89%。向全体股东每10股派发现金红利1.6元(含税)。公司归属于上市公司股东的扣除非经常性损益的净利润主要源于实验室服务业务利润和资金...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2422157502?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-03-28 17:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2422157502","market":"us","top_or_hot":-1,"title":"昭衍新药(603127.SH)发2023年业绩，净利润3.97亿元，同比下降63.04%","media":"智通财经","content":"<div>\n<p>智通财经APP讯，昭衍新药(603127.SH)发布2023年年度报告，实现营业收入23.76亿元，同比增长4.78%。实现归属于上市公司股东的净利润3.97亿元，同比下降63.04%。实现归属于上市公司股东的扣除非经常性损益的净利润3.38亿元，同比下降66.89%。向全体股东每10股派发现金红利1.6元(含税)。公司归属于上市公司股东的扣除非经常性损益的净利润主要源于实验室服务业务利润和资金...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1094846.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>昭衍新药(603127.SH)发2023年业绩，净利润3.97亿元，同比下降63.04%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n昭衍新药(603127.SH)发2023年业绩，净利润3.97亿元，同比下降63.04%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-28 17:55 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1094846.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，昭衍新药(603127.SH)发布2023年年度报告，实现营业收入23.76亿元，同比增长4.78%。实现归属于上市公司股东的净利润3.97亿元，同比下降63.04%。实现归属于上市公司股东的扣除非经常性损益的净利润3.38亿元，同比下降66.89%。向全体股东每10股派发现金红利1.6元(含税)。公司归属于上市公司股东的扣除非经常性损益的净利润主要源于实验室服务业务利润和资金...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1094846.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06127","symbol_name":"昭衍新药","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1094846.html","article_id":"2422157502","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2422157502","pubTimestamp":1711619734,"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，昭衍新药(603127.SH)发布2023年年度报告，实现营业收入23.76亿元，同比增长4.78%。实现归属于上市公司股东的净利润3.97亿元，同比下降63.04%。实现归属于上市公司股东的扣除非经常性损益的净利润3.38亿元，同比下降66.89%。向全体股东每10股派发现金红利1.6元(含税)。公司归属于上市公司股东的扣除非经常性损益的净利润主要源于实验室服务业务利润和资金管理收益，以及生物资产市价波动的共同影响。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"06127":"昭衍新药"},"translate_title":"Zhaoyan New Drug (603127. sh) issued its 2023 results with a net profit of 397 million yuan, down 63.04% year-on-year","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06127":1},"content_text":"智通财经APP讯，昭衍新药(603127.SH)发布2023年年度报告，实现营业收入23.76亿元，同比增长4.78%。实现归属于上市公司股东的净利润3.97亿元，同比下降63.04%。实现归属于上市公司股东的扣除非经常性损益的净利润3.38亿元，同比下降66.89%。向全体股东每10股派发现金红利1.6元(含税)。公司归属于上市公司股东的扣除非经常性损益的净利润主要源于实验室服务业务利润和资金管理收益，以及生物资产市价波动的共同影响。","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2422157502"}